You are here

oncology

Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug

Yahoo/Reuters

Mon, 05/19/25 - 10:33 pm

non-small cell lung cancer

metastatic colorectal cancer

Saving pediatric cancer drugs from the ‘valley of death’

Beckers Hospital Review

Fri, 05/16/25 - 11:23 am

drug development

In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen

Fierce Pharma

Thu, 05/8/25 - 10:56 pm

J&J survey finds pace of oncology innovation is overwhelming physicians

Fierce Pharma

Thu, 05/8/25 - 11:17 am

AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent

Pharmaphorum

Tue, 04/29/25 - 08:11 am

Ascentage Pharma

Mosaic adds to cancer combo pattern by licensing 2 clinical-stage drugs from Astex

Fierce Biotech

Thu, 04/24/25 - 10:50 am

Mosaic Therapeutics

Astex Pharmaceuticals

Boehringer to expand oncology presence with $572m Tessellate Bio deal

Pharmaceutical Technology

Wed, 04/23/25 - 09:42 am

Boehringer Ingelheim

NAYA Biosciences spins off cancer drug business 6 months after INVO merger

Fierce Biotech

Tue, 04/15/25 - 09:51 am

NAYA Biosciences

From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’

Fierce Biotech

Wed, 04/9/25 - 10:59 pm

radiopharmaceuticals

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite Merck-Halozyme patent drama

Fierce Pharma

Mon, 03/17/25 - 10:11 pm

subcutaneous drug delivery

Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do

Pharma Voice

Mon, 03/17/25 - 10:13 am

radiopharmaceuticals

Ratio Therapeutics

Radiopharm Theranostics

‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after restructuring

Fierce Biotech

Thu, 03/13/25 - 11:21 pm

Project Optimus: helping or hindering cancer drug development?

Clinical Trials Arena

Thu, 03/6/25 - 10:06 pm

Project Optimus

drug development

Its CEO died. The company scrapped a promising program. Now, for their 2nd act.

Pharma Voice

Thu, 02/27/25 - 10:12 am

Terns Pharmaceuticals

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Motley Fool

Sun, 01/26/25 - 04:13 pm

J&J oncology sales grow, but shares slide on outlook

BioPharma Dive

Wed, 01/22/25 - 12:01 pm

Multiple Myeloma

Pfizer, under pressure to change, names oncology head as new R&D chief

BioPharma Dive

Wed, 11/20/24 - 11:33 am

Pharma’s grip on cancer R&D is having unintended consequences

Pharma Voice

Wed, 11/13/24 - 10:52 am

After Pfizer deal, former Seagen CEO returns to lead oncology startup

BioPharma Dive

Mon, 10/28/24 - 11:10 am

cancer immunotherapy

Pages